Home All News

All News

Internet And Biotech Related News

Nightmare on Crypto Street.

A lot going last week, and none of it good. Unless you've been on the sidelines - waiting and waiting..and waiting,...

Smart for Life (SMFL) $0.43 on Track to Close Pending Acquisition of Ceautamed Worldwide.

Has Smart for Life Found a Base at $0.45? Market Action Aside, We Think So. Report Out Monday.

1.9 Trillion Trades on OTCMarkets in May. Thumbs up or Buyer Beware?

An increase of more than 2,000 percent from a year earlier! Penny...

Revive’s Quarterly Report, Discussion, and a Video!

With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it....
Revive Therapeutics

Revive Therapeutics Gains 25% on Positive FDA Comments.

The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...

Soona Amhaz, Bags $50 Million for New Crypto Fund

“I think it’s a phenomenal time to be investing,” Amhaz said. “This is the exact right time to be doubling down.”
Internet Stock Review

Internet Stock Review Relaunches After 23 Years.

Our First Broad Based Recommended Watch List in Over Two Decades! First name to our list of 20, is...

Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.

We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added...

Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?

Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found...

‘Big Short’ investor Michael Burry warns stocks will crash and rallies won’t last.

Here's a roundup of his recent tweets and what they mean. (BusinessInsider) Michael Burry, the hedge fund manager...

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...